Study Coming Soon – Phase I Clinical Research Study – HYR-PB21

Frontage Clinical Services prioritizes the safety and well-being of our study participants, our employees, and visitors to our clinic. As such, we have incorporated additional policies and procedures, as recommended by the CDC.

Participate in a Phase I Clinical Trial

Frontage Clinical Services is seeking healthy adult volunteers to participate in a Phase I clinical research study evaluating HYR-PB21, an investigational long-acting local anesthetic. The study will assess the safety, tolerability, and pharmacokinetics (how the body processes the drug) of HYR-PB21 compared to standard Bupivacaine HCl Injection.

To participate, you must:

  • Be a Healthy Adult
  • Be 18 to 55 years old
  • Have a BMI between 18.0 and 32.0 kg/m² (Must be at least 110lbs)
  • Have a Good Venous Access

Study Requirements:

  • 7 overnight (6 days) stays at the research unit followed by 1 outpatient visit.
  • A double abdominal injection of investigational study medication
  • Compensation up to $3,850 for your time and participation.

Application for Clinical Research Study

Study Coming Soon – Phase I Clinical Research Study – HYR-PB21

Your information will be used solely for research recruitment purposes by our research team and will not be shared externally. All submissions are stored securely in accordance with HIPAA and Good Clinical Practice (GCP) standards.

Please fill out all required fields.